Katayama Tatsuya, Hirai Shinji
Department of Cardiovascular and Thoracic Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Kyobu Geka. 2017 Feb;70(2):111-113.
Two 50s female patients with the taste disorder of sweet taste loss and stage IV a type B2 invasive thymoma underwent surgery at our hospital. One patient with myasthenia gravis (MG) developed postoperative myasthenic crisis and recovered by the treatment with plasma apheresis and steroid pulse therapy. Her taste disorder fully recovered together with her MG symptom. The taste disorder of the other patient without MG had persisted for 3 years after the surgery. The taste disorder of sweet taste loss was reported as one of non-motor symptoms caused by MG-related autoimmune mechanisms associated with thymoma, improving with the therapy for MG. Anti-Kv 1.4 antibody was reported to be positive in nearly half patients with the taste disorder and MG and is speculated to affect selectively the sweet taste receptor.
我院收治了两名50多岁的女性患者,她们均患有甜味丧失味觉障碍且为IV期B2型侵袭性胸腺瘤,并接受了手术治疗。其中一名患有重症肌无力(MG)的患者术后发生了重症肌无力危象,经血浆置换和类固醇冲击疗法治疗后康复。她的味觉障碍与MG症状一同完全恢复。另一名没有MG的患者术后味觉障碍持续了3年。甜味丧失味觉障碍被报道为与胸腺瘤相关的MG自身免疫机制引起的非运动症状之一,随着MG治疗而改善。据报道,近半数有味觉障碍和MG的患者抗Kv 1.4抗体呈阳性,推测其对甜味受体有选择性影响。